Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087022
Status:
COMPLETED
Last Update Posted:
2018-11-27
First Post:
2004-07-08
Brief Title:
Monoclonal Antibody Therapy Rencarex in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Sponsor:
Heidelberg Pharma AG
Organization:
Heidelberg Pharma AG
Organization Data
Organization:
Heidelberg Pharma AG
Class:
INDUSTRY
Study ID:
WX-2003-07-HR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Heidelberg Pharma AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None